Journal of Pharmaceutical Analysis (Dec 2013)

Method development and validation of Guanfacine in rat plasma by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study

  • Suryanarayana Murthy Goparaju,
  • Yadagiri Srinivasa Murthy Nandula,
  • Chandrasekher Bannoth Kothapalli,
  • B.R. Challa,
  • Bahlul Z. Awen

Journal volume & issue
Vol. 3, no. 6
pp. 472 – 480

Abstract

Read online

A selective, sensitive and high-throughput liquid chromatography–tandem mass spectrometry (LC–ESI-MS/MS) method has been developed and validated for the quantitation of Guanfacine in rat plasma. Sample clean-up involved liquid–liquid extraction (LLE) and 100 μL of rat plasma was used. YMC BASIC column (50 mm×2.0 mm, 3.5 µm) was used. Mobile phase used was 10 mM ammonium formate (pH 4.0):acetonitrile (70:30, v/v) at a flow rate of 0.3 mL/min. The parent→product ion transitions for the drug (m/z 246.0→159.0) and IS (m/z 252.0→161.1) were monitored on a triple quadrupole mass spectrometer, operating in the multiple reaction monitoring (MRM) and positive ion mode. The method was validated over the concentration range of 50.00–10,000.00 pg/mL for Guanfacine. The method was successfully applied into a pharmacokinetic study in rat plasma. Keywords: Guanfacine, LC–ESI-MS/MS, Rat plasma, Liquid–liquid extraction, Pharmacokinetic study